ARCT's logo.
Ticker Symbol: ARCT

Arcturus Therapeutics Holdings Inc

$37.36 - 21-07-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001768224

Company Profile

founded in 2013 and based in san diego, calif., arcturus therapeutics is poised to become an industry leader in the application of rnai technologies for the treatment of disease and improved quality of life. the company’s aim is to develop breakthrough technology and novel therapeutics for rare diseases for which there is no adequate treatment. backed by a management team with extensive experience in the discovery and development of therapeutic modalities, arcturus is on the forefront of research and development of nanoparticle sirna drug delivery systems.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
CEO: N/A
Tags:
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $20.18
Change: -$0.42 ( -2.04%)
Days Range: $20.18 - $21.05
Beta: 1.29
52wk. High: $37.75
52wk. Low: $13.88
Ytd. Change 16.95%
50 Day Moving Average: $26.31
200 Day Moving Average: $28.47
Shares Outstanding: 26598539

Valuation

Market Cap: 53.7B
PE Ratio: 6.86
EPS (TTM): 2.94

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A